AIMx is a family-owned company with one focus: giving podiatrists access to the best regenerative cash-pay solutions in the market, backed by people who actually pick up the phone.
We saw a gap and built something different. AIMx is a podiatric-specific regenerative company with a portfolio designed from the ground up for the conditions podiatrists actually treat every day.
We went all in on podiatry. Not orthopedics. Not aesthetics. Not everything regenerative. Just podiatry. People ask us why we do not expand into other specialties. The answer is simple. We love this field. We love the doctors. We love the mindset. And we want to be a true partner to podiatry practices, not just another vendor.
Today we partner with 200+ podiatrists across the United States. We run quarterly regenerative medicine education events, stay on the leading edge of what is coming next in the space, and show up for our partners the way a real partner should.
From advanced biologics to practical clinical solutions, AIMx Podiatry delivers what today’s podiatrist needs to treat confidently, grow sustainably, and lead with innovation.
When John and his family built AIMx Podiatry, they had one belief: regenerative medicine is the future of medicine, and podiatrists deserved a company fully dedicated to that future. With more than 15 years of experience in regenerative medicine and biologics, John has spent his career in this space and recognized that podiatrists needed a true partner focused on their practices and their patients.
AIMx was built on a few non negotiables: compliant products, honest information, and showing up as a real partner to every practice served. John believes every patient should have access to regenerative medicine, which means building affordable solutions that make that possible.
For John, success is simple: being a trusted partner to the podiatry community, helping patients get better, and delivering products that do exactly what they are supposed to do.
In 2024, I joined my family at AIMx with a shared vision of advancing regenerative medicine within podiatry. Prior to that, I spent over a decade in the dental space, where I saw how practices adopt new technologies that improve outcomes and grow their business. It quickly became clear how similar podiatry is and the opportunity in front of it. My focus is helping doctors implement regenerative solutions in a way that’s practical, compliant, and financially sound. What I take the most pride in is the partnerships we’ve built around products that truly perform. When outcomes are strong, our job becomes simple, clearly communicating the value and making implementation easy. What’s carried over from my previous role is the enjoyment of building relationships with doctors and seeing the real impact it has on their patients. It’s about being a trusted partner, helping practices grow, and improving patient outcomes. I couldn’t be more excited about the partnerships we’re building, the doctors we’re meeting, and the future of where this is all headed.
Justin cares deeply about the people behind the practice, both the doctors and the patients they serve. With a background in architecture, Justin naturally brings a thoughtful eye for detail and a focus on building strong, well-structured systems that support everyone’s success.
Justin takes pride in being hands-on and approachable, working closely with physicians to make sure they feel supported, respected, and set up to do their best work. Creating a positive experience for both providers and patients isn’t just a goal, it’s something he works toward every single day.
From advanced biologics to practical clinical solutions, AIMx Podiatry delivers what today’s podiatrist needs to treat confidently, grow sustainably, and lead with innovation.

Address the painful effects of fat pad atrophy with Liposana®. This innovative, minimally invasive solution helps you provide lasting relief by restoring essential cushioning to your patients' feet. It's a highly sought-after, patient-funded treatment that enhances comfort and mobility, setting your practice apart.

DPMx is derived from umbilical cord structural tissue, which is naturally composed of extracellular matrix components such as collagen, elastin, and hyaluronan. The natural properties of this tissue may provide structural support and contribute to maintaining integrity, flexibility, and cushioning in areas of use.

Go beyond conventional approaches. Our physician-dispensed oral peptides are designed to work with the body’s natural processes, giving providers flexible options to incorporate into a wide range of patient care protocols.
From advanced biologics to practical clinical solutions, AIMx Podiatry delivers what today’s podiatrist needs to treat confidently, grow sustainably, and lead with innovation.
© 2026 AIMx Podiatry. All rights reserved.